Chitosan: some pharmaceutical and biological aspects ‐ an update

Chitosan, a natural polysaccharide, is being widely used as a pharmaceutical excipient. It is obtained by the partial deacetylation of chitin, the second most abundant natural polymer. Chitosan comprises a series of polymers varying in their degree of deacetylation, molecular weight, viscosity, pKa etc. The presence of a number of amino groups permit chitosan to chemically react with anionic systems, thereby resulting in alteration of physicochemical characteristics of such combinations.

[1]  C. S. Chen,et al.  Antibacterial effects of N-sulfonated and N-sulfobenzoyl chitosan and application to oyster preservation. , 1998, Journal of food protection.

[2]  T. Ohe Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. , 1996, The Science of the total environment.

[3]  R. Tasker,et al.  Pharmacokinetics of an injectable sustained-release formulation of morphine for use in dogs. , 1997, Journal of veterinary pharmacology and therapeutics.

[4]  K. Deuchi,et al.  Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet. , 1995, Bioscience, biotechnology, and biochemistry.

[5]  S. Davis,et al.  In vitro evaluation of the mucoadhesive properties of chitosan microspheres , 1998 .

[6]  C. Stone,et al.  Healing at skin graft donor sites dressed with chitosan. , 2000, British journal of plastic surgery.

[7]  H. Kaş,et al.  Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. , 1995, Die Pharmazie.

[8]  G. Tsai,et al.  Antibacterial activity of shrimp chitosan against Escherichia coli. , 1999, Journal of food protection.

[9]  V. Dodane,et al.  Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.

[10]  J. Lehoux,et al.  Some effects of chitosan on liver function in the rat. , 1993, Endocrinology.

[11]  K. Ingvarsdóttir,et al.  Chitosan Matrix Tablets: The Influence of Excipients on Drug Release , 1995 .

[12]  T. Fujita,et al.  Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. , 1999, Life sciences.

[13]  S. Bolton,et al.  INVESTIGATION OF PROLONGED DRUG RELEASE FROM MATRIX FORMULATIONS OF CHITOSAN , 1990 .

[14]  W. Paul,et al.  Chitosan, a drug carrier for the 21st century : a review , 2000 .

[15]  T J Smith,et al.  Chitosan‐membrane interactions and their probable role in chitosan‐mediated transfection , 1998, Biotechnology and applied biochemistry.

[16]  K. E. Gabr,et al.  Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCl , 1993 .

[17]  A. Sezer,et al.  Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. , 1999, Journal of microencapsulation.

[18]  Y. Murata,et al.  Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads , 1996 .

[19]  E. C. Sung,et al.  The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[20]  G. Macleod,et al.  The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[21]  R. Ilango,et al.  Dissolution studies on tablets of ibuprofen using chitosan. , 1999, Indian journal of experimental biology.

[22]  G. Kind,et al.  Chitosan: evaluation of a new hemostatic agent. , 1990, Current surgery.

[23]  S. Lin,et al.  The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. , 1985, Chemical & pharmaceutical bulletin.

[24]  T. Miller,et al.  Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. , 1998, Atherosclerosis.

[25]  Y. Kikuchi,et al.  Polyelectrolyte Complexes of Chitosan with Sodium Carboxymethyldextran , 1978 .

[26]  L. Hall,et al.  Some chemical and analytical aspects of polysaccharide modifications. III. Formation of branched-chain, soluble chitosan derivatives , 1984 .

[27]  F. Smales,et al.  In vitro assessment of bioadhesion for periodontal and buccal drug delivery. , 1995, Biomaterials.

[28]  R. Qaqish,et al.  Evaluation of the Factors Influencing Stomach‐specific Delivery of Antibacterial Agents for Helicobacter pylori Infection , 1999, The Journal of pharmacy and pharmacology.

[29]  H. Junginger,et al.  Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[30]  H. Saitǒ,et al.  Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans , 1991 .

[31]  P Buri,et al.  Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.

[32]  J. Kreuter,et al.  Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs , 1996 .

[33]  F. Mi,et al.  Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. , 1997, Journal of microencapsulation.

[34]  M. Meshali,et al.  A new approach to encapsulating nonsteroidal anti-inflammatory drugs. IV. Effect of cellulose derivatives with different functional groups on the bioavailability and gastric ulcerogenic activity of acidic as well as basic nonsteroidal anti-inflammatory drugs. , 1989, Journal of microencapsulation.

[35]  C. P. Sharma,et al.  Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.

[36]  M. Pasta,et al.  Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack. , 1998, Journal of pharmaceutical sciences.

[37]  R. Duncan,et al.  Evaluation of the biological properties of soluble chitosan and chitosan microspheres , 1997 .

[38]  W. Rainer,et al.  Chitosan: a new hemostatic. , 1983, The Annals of thoracic surgery.

[39]  G. Buckton,et al.  Modelling mucoadhesion by use of surface energy terms obtained by the Lewis acid-Lewis base approach , 1995 .

[40]  M A Bayomi,et al.  Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. , 1998, Pharmaceutica acta Helvetiae.

[41]  T. Fujita,et al.  Validation of a Pharmacokinetic Model of Colon‐specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5‐Aminosalicylic Acid on 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats , 1999, The Journal of pharmacy and pharmacology.

[42]  H. Doorne,et al.  Stability and in vitro activity of nystatin and its γ-cyclodextrin complex against Candida albicans , 1991 .

[43]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[44]  P. Perugini,et al.  Different molecular weight chitosan microspheres: influence on drug loading and drug release. , 1998, Drug development and industrial pharmacy.

[45]  J. Anderson,et al.  A Comparison of the Lipid-Lowering and Intestinal Morphological Effects of Cholestyramine, Chitosan, and Oat Gum in Rats , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[46]  Claus-Michael Lehr,et al.  Bioadhesive polymers for the peroral delivery of peptide drugs , 1994 .

[47]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[48]  S. Harding,et al.  Hydrodynamic characterization of chitosans varying in degree of acetylation. , 1993, International journal of biological macromolecules.

[49]  M. Wada,et al.  Accelerating effect of chitosan intake on urinary calcium excretion by rats. , 1997, Bioscience, biotechnology, and biochemistry.

[50]  V. Zecchi,et al.  Controlled Insulin Release from Chitosan Microparticles , 1998, Archiv der Pharmazie.

[51]  김동만,et al.  Rheological properties , 1992, Physics Subject Headings (PhySH).

[52]  A. Bernkop‐Schnürch,et al.  Chitosan‐EDTA Conjugate: A Novel Polymer for Topical Gels , 1998, The Journal of pharmacy and pharmacology.

[53]  C. Yomota,et al.  [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate]. , 1990, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences.

[54]  C. Yomota,et al.  [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate]. , 1994, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[55]  Tatsuaki Yamaguchi,et al.  Effect of Chitosan on Renal Function in Patients with Chronic Renal Failure , 1997, The Journal of pharmacy and pharmacology.

[56]  H Lennernäs,et al.  Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  L-K Han,et al.  Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet , 1999, International Journal of Obesity.

[58]  J. Kristl,et al.  Hydrocolloids and gels of chitosan as drug carriers , 1993 .

[59]  T. Imai,et al.  Enhancement of Dissolution Rates of Several Drugs by Low-Molecular Chitosan and Alginate , 1990 .

[60]  María J. Alonso,et al.  Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration , 1999 .

[61]  A. Hoekstra,et al.  Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. , 1998, Biomaterials.

[62]  C. Remuñán-López,et al.  Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine , 1998 .

[63]  L. Lim,et al.  Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. , 1998, Journal of Microencapsulation.

[64]  A. Bernkop‐Schnürch,et al.  Basic studies on bioadhesive delivery systems for peptide and protein drugs , 1998 .

[65]  H. Yamahara,et al.  Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force. , 1997, Chemical and pharmaceutical bulletin.

[66]  A. Perkins,et al.  Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.

[67]  T. Nagai,et al.  Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate , 1990 .

[68]  M. Alonso,et al.  Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[69]  T. Masada,et al.  Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.

[70]  Pruthvipathy R. Katikaneni,et al.  Chitosan as a tablet binder , 1992 .

[71]  Y. Murata,et al.  Preparation and drug retention of biodegradable chitosan gel beads. , 1999, Chemical & pharmaceutical bulletin.

[72]  F. Otero-Espinar,et al.  Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[73]  L. Illum,et al.  Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.

[74]  E. Wuolijoki,et al.  Decrease in serum LDL cholesterol with microcrystalline chitosan. , 1999, Methods and findings in experimental and clinical pharmacology.

[75]  L. Block,et al.  Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. , 1997, Pharmaceutical development and technology.

[76]  S. Davis,et al.  Chitosan microspheres prepared by spray drying. , 1999, International journal of pharmaceutics.

[77]  R. Neufeld,et al.  DNA protection from extracapsular nucleases, within chitosan- or poly-L-lysine-coated alginate beads. , 1998, Biotechnology and bioengineering.

[78]  D. Attwood,et al.  Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. , 1994, Biological & pharmaceutical bulletin.

[79]  P. Darcy,et al.  The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate , 1995 .

[80]  Y. Okamoto,et al.  Evaluation of chitin and chitosan on open would healing in dogs. , 1995, The Journal of veterinary medical science.

[81]  E. Ernst,et al.  Randomized, double-blind trial of chitosan for body weight reduction , 1999, European Journal of Clinical Nutrition.

[82]  K. Deuchi,et al.  Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. , 1995, Bioscience, biotechnology, and biochemistry.

[83]  T. Maruyama,et al.  Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. , 1996, Journal of pharmaceutical sciences.

[84]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[85]  L. Block,et al.  Chitinosans as tableting excipients for modified release delivery systems. , 1999, International journal of pharmaceutics.

[86]  A. Bernkop‐Schnürch,et al.  Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[87]  G. Mahrous,et al.  Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. , 1998, Journal of microencapsulation.

[88]  J. Smart,et al.  An in vitro mucosal model predictive of bioadhesive agents in the oral cavity. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[89]  S. Davis,et al.  Sustained release chitosan microspheres prepared by novel spray drying methods. , 1999, Journal of microencapsulation.

[90]  J. Akbuǧa,et al.  The effect of the physicochemical properties of a drug on its release from chitosonium malate matrix tablets , 1993 .

[91]  Y. Okamoto,et al.  Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2. , 1998, Journal of biomedical materials research.

[92]  M. Ishihara,et al.  Photocrosslinkable chitosan as a biological adhesive. , 2000, Journal of biomedical materials research.

[93]  Y. Seino,et al.  Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. , 1995, Biological & pharmaceutical bulletin.

[94]  T. Ohno,et al.  Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres , 1997 .

[95]  H. Junginger,et al.  Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .

[96]  J. Schwartz,et al.  Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. , 1999, Pharmaceutical development and technology.

[97]  A. Bernkop‐Schnürch Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. , 2000, International journal of pharmaceutics.

[98]  C. Pruzzo,et al.  Inhibition of Streptococcus mutans Adsorption to Hydroxyapatite by Low-molecular-weight Chitosans , 1997, Journal of dental research.

[99]  J. Akbuğa,et al.  Effect of formulation variables on cis-platin loaded chitosan microsphere properties. , 1999, Journal of microencapsulation.

[100]  B. Connell,et al.  Development of an injectable sustained-release formulation of morphine: antinociceptive properties in rats , 1998, Laboratory animals.

[101]  D. Grant,et al.  Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides. , 1998, Drug development and industrial pharmacy.

[102]  K. Sall,et al.  The effect of chitosan on corneal wound healing. , 1987, Annals of ophthalmology.

[103]  M. Kawai,et al.  Rheological properties and fractal structure of concentrated polyion complexes of chitosan and alginate. , 1993, Biorheology.

[104]  H. Kaş Chitosan: properties, preparations and application to microparticulate systems. , 1997, Journal of microencapsulation.

[105]  H. Junginger,et al.  Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[106]  L. Opletal,et al.  [Phytotherapeutic aspects of diseases of the circulatory system. 4. Chitin and chitosan]. , 1995, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.

[107]  M. Takada,et al.  Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. , 1988, Chemical & pharmaceutical bulletin.

[108]  D. Attwood,et al.  Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate , 1995 .

[109]  M. Sargon,et al.  Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. , 2000, International journal of pharmaceutics.

[110]  Y. Yamamoto,et al.  Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. , 1990, Chemical & pharmaceutical bulletin.

[111]  G. Smistad,et al.  Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .

[112]  P. Cullis,et al.  Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.

[113]  I. Gouda,et al.  Heparin-chitosan complexes stimulate wound healing in human skin. , 1997, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[114]  H. Hayatsu,et al.  Polynucleotide-chitosan complex, an insoluble but reactive form of polynucleotide. , 1997, Chemical & pharmaceutical bulletin.

[115]  F. Bartone,et al.  Chitosan: effects on wound healing in urogenital tissue: preliminary report. , 1988, The Journal of urology.

[116]  R. Duncan,et al.  Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.

[117]  J. Torres,et al.  Chitosan‐Poly(acrylic acid): Mechanism of Complex Formation and Potential Industrial Applications , 1990, Biotechnology progress.

[118]  T. Nagai,et al.  Use of chitosan for sustained-release preparations of water-soluble drugs. , 1982, Chemical & pharmaceutical bulletin.